Kunkel Lori Anne
- SEC CIK
- 0001536368
In the past year, 2 open-market sale filings worth $850.3K and no purchases.
Current role at each company
- ELVN Enliven Therapeutics, Inc.Directoras of Jul 8, 2026
- ORIC Oric Pharmaceuticals, Inc.Directoras of Jan 6, 2026
- NRIX Nurix Therapeutics, Inc.Directoras of May 19, 2025
- CRIS Curis IncDirectoras of Jan 31, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $850.3K
- 2 filings
- Net
- −$850.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kunkel Lori Anne as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ELVN Enliven Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Kunkel Lori AnneDirector | SSale | −10.0K | $34.54 | −$345.4K | −16.2%51.9K after | 3 lots10b5-1 |
| Jul 8, 2026 (view filing)5:15 PM ET | Jul 6 | 2 days | Kunkel Lori AnneDirector | SSale | −10.0K | $50.49 | −$504.9K | −19.3%41.9K after | 2 lots10b5-1 |